SPX4,236.17-47.57 -1.11%
DIA337.51-2.41 -0.71%
IXIC12,739.12-226.22 -1.74%

BRIEF-Statement By HHS Secretary Becerra On FDA Approval Of Additional Bavarian Nordic Monkeypox Vaccine

BRIEF-Statement By HHS Secretary Becerra On FDA Approval Of Additional Bavarian Nordic Monkeypox Vaccine

Reuters · 07/27/2022 12:06
BRIEF-Statement By HHS Secretary Becerra On FDA Approval Of Additional Bavarian Nordic Monkeypox Vaccine

-

  • STATEMENT BY HHS SECRETARY BECERRA ON FDA APPROVAL OF ADDITIONAL BAVARIAN NORDIC MONKEYPOX VACCINE

  • HHS SECRETARY SAYS APPROVAL BY FDA OF BAVARIAN NORDIC’S FILL-&-FINISH CAPABILITIES MEANS ADDITIONAL 786,000 DOSES OF VACCINE ARE NOW AVAILABLE FOR USE IN U.S

  • HHS SECRETARY SAYS HHS WORKING TO MAKE VACCINE DOSES AVAILABLE TO STATES & JURISDICTIONS AS SOON AS POSSIBLE, WILL ANNOUNCE ALLOCATIONS TOMORROW


((Reuters.Briefs@thomsonreuters.com;))